vs
NORTHRIM BANCORP INC（NRIM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NORTHRIM BANCORP INC的1.1倍（$69.8M vs $61.2M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 11.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 18.4%）
Northrim Bancorp Inc是总部位于美国阿拉斯加州的区域银行控股企业，提供商业及个人存贷款、按揭产品、财富管理等多元化金融服务，服务覆盖本地小微企业、个人消费者及企业客户群体。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NRIM vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$61.2M
营收增速更快
RIGL
高出9.6%
11.6%
两年增速更快
RIGL
近两年复合增速
18.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.2M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 79.9% | 91.5% |
| 营业利润率 | 27.2% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 11.6% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-2.80 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRIMRIGL
| Q4 25 | $61.2M | $69.8M | ||
| Q3 25 | $77.2M | $69.5M | ||
| Q2 25 | $61.4M | $101.7M | ||
| Q1 25 | $55.8M | $53.3M | ||
| Q4 24 | $54.8M | $57.6M | ||
| Q3 24 | $51.0M | $55.3M | ||
| Q2 24 | $46.5M | $36.8M | ||
| Q1 24 | $43.7M | $29.5M |
净利润NRIMRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $27.1M | $27.9M | ||
| Q2 25 | $11.8M | $59.6M | ||
| Q1 25 | $13.3M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $8.8M | $12.4M | ||
| Q2 24 | $9.0M | $-1.0M | ||
| Q1 24 | $8.2M | $-8.2M |
毛利率NRIMRIGL
| Q4 25 | 79.9% | 91.5% | ||
| Q3 25 | 84.0% | 93.2% | ||
| Q2 25 | 78.5% | 95.6% | ||
| Q1 25 | 84.1% | 91.7% | ||
| Q4 24 | 77.8% | 89.9% | ||
| Q3 24 | 75.2% | 85.5% | ||
| Q2 24 | 79.1% | 92.4% | ||
| Q1 24 | 78.2% | 93.1% |
营业利润率NRIMRIGL
| Q4 25 | 27.2% | 33.2% | ||
| Q3 25 | 44.8% | 40.9% | ||
| Q2 25 | 25.7% | 60.1% | ||
| Q1 25 | 31.5% | 23.9% | ||
| Q4 24 | 24.3% | 28.9% | ||
| Q3 24 | 22.8% | 25.4% | ||
| Q2 24 | 24.9% | 1.2% | ||
| Q1 24 | 24.1% | -23.6% |
净利率NRIMRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 35.1% | 40.2% | ||
| Q2 25 | 19.2% | 58.6% | ||
| Q1 25 | 23.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 17.3% | 22.5% | ||
| Q2 24 | 19.4% | -2.8% | ||
| Q1 24 | 18.8% | -27.9% |
每股收益（稀释后）NRIMRIGL
| Q4 25 | $-2.80 | $14.11 | ||
| Q3 25 | $1.20 | $1.46 | ||
| Q2 25 | $2.09 | $3.28 | ||
| Q1 25 | $2.38 | $0.63 | ||
| Q4 24 | $-1.83 | $0.82 | ||
| Q3 24 | $0.39 | $0.70 | ||
| Q2 24 | $1.62 | $-0.06 | ||
| Q1 24 | $1.48 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $12.8M | $52.5M |
| 股东权益账面价值 | $326.5M | $391.5M |
| 总资产 | $3.3B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.04× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NRIMRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务NRIMRIGL
| Q4 25 | $12.8M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $23.0M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NRIMRIGL
| Q4 25 | $326.5M | $391.5M | ||
| Q3 25 | $315.7M | $117.6M | ||
| Q2 25 | $290.2M | $81.9M | ||
| Q1 25 | $279.8M | $18.6M | ||
| Q4 24 | $267.1M | $3.3M | ||
| Q3 24 | $260.1M | $-14.6M | ||
| Q2 24 | $247.2M | $-29.9M | ||
| Q1 24 | $239.3M | $-31.7M |
总资产NRIMRIGL
| Q4 25 | $3.3B | $513.6M | ||
| Q3 25 | $3.3B | $242.5M | ||
| Q2 25 | $3.2B | $206.7M | ||
| Q1 25 | $3.1B | $176.0M | ||
| Q4 24 | $3.0B | $164.0M | ||
| Q3 24 | $3.0B | $139.4M | ||
| Q2 24 | $2.8B | $128.4M | ||
| Q1 24 | $2.8B | $126.5M |
负债/权益比NRIMRIGL
| Q4 25 | 0.04× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.09× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $139.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $133.9M | — |
| 自由现金流率自由现金流/营收 | 218.9% | — |
| 资本支出强度资本支出/营收 | 8.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $235.4M | — |
8季度趋势，按日历期对齐
经营现金流NRIMRIGL
| Q4 25 | $139.3M | $22.0M | ||
| Q3 25 | $92.7M | $24.0M | ||
| Q2 25 | $-4.4M | $30.5M | ||
| Q1 25 | $16.5M | $-893.0K | ||
| Q4 24 | $-8.7M | $14.5M | ||
| Q3 24 | $-201.0K | $21.7M | ||
| Q2 24 | $-38.5M | $302.0K | ||
| Q1 24 | $-5.5M | $-5.0M |
自由现金流NRIMRIGL
| Q4 25 | $133.9M | — | ||
| Q3 25 | $89.9M | — | ||
| Q2 25 | $-4.7M | — | ||
| Q1 25 | $16.3M | — | ||
| Q4 24 | $-9.3M | — | ||
| Q3 24 | $-330.0K | — | ||
| Q2 24 | $-39.4M | — | ||
| Q1 24 | $-6.6M | — |
自由现金流率NRIMRIGL
| Q4 25 | 218.9% | — | ||
| Q3 25 | 116.5% | — | ||
| Q2 25 | -7.7% | — | ||
| Q1 25 | 29.3% | — | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -0.6% | — | ||
| Q2 24 | -84.7% | — | ||
| Q1 24 | -15.1% | — |
资本支出强度NRIMRIGL
| Q4 25 | 8.9% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.4% | — |
现金转化率NRIMRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 3.42× | 0.86× | ||
| Q2 25 | -0.37× | 0.51× | ||
| Q1 25 | 1.24× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -0.02× | 1.75× | ||
| Q2 24 | -4.27× | — | ||
| Q1 24 | -0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NRIM
| Community Banking Segment | $44.3M | 72% |
| Specialty Finance Segment | $7.4M | 12% |
| Other | $4.7M | 8% |
| Home Mortgage Lending Segment | $3.6M | 6% |
| Credit And Debit Card | $1.2M | 2% |
RIGL
暂无分部数据
